Picture of Adagene logo

ADAG Adagene Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Annual cashflow statement for Adagene, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUS20-F20-F20-F20-F
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-16.4-42.4-73.2-80-18.9
Depreciation
Non-Cash Items-0.61910.819.38.286.06
Unusual Items
Other Non-Cash Items
Changes in Working Capital-1.922.239.3521.9-16.6
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Cash from Operating Activities-18.2-28.5-43.4-48.6-28.5
Capital Expenditures-0.152-0.935-2.51-0.691-0.085
Purchase of Fixed Assets
Other Investing Cash Flow Items258.0100.0050.008
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities24.97.07-2.51-0.686-0.077
Financing Cash Flow Items-0.722-1.600
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities69.74.4414517.8-5.37
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash76.5-17.499.2-30.6-33.8